```html

Comprehensive Medical Guide to Lung Pneumonia

Overview

Pneumonia is an infection that inflames the air sacs (alveoli) in one or both lungs. The sacs may fill with fluid or pus, causing cough, fever, chills, and difficulty breathing. When the infection originates in the lungs, it is commonly called lung pneumonia to distinguish it from other forms of pneumonia that affect the throat or bronchi.

It can be caused by bacteria, viruses, fungi, or parasites, and the severity ranges from mild, treatable illness to life‑threatening disease.

Who it affects

• Children under 5 years – especially those in low‑resource settings.
• Adults over 65 – immune function declines with age.
• People with chronic medical conditions such as COPD, heart disease, diabetes, or weakened immune systems.
• Smokers and people exposed to air pollutants.

Prevalence

According to the World Health Organization (WHO), pneumonia accounts for over 2.5 million deaths each year worldwide, making it the leading infectious cause of death among children under five. In the United States, the CDC reports about 1 million adult hospitalizations annually, with an estimated cost of $17 billion (CDC, 2022). The incidence rises sharply with age: adults ≥ 65 experience roughly 1.5 million cases per year.

Symptoms

Symptoms can develop suddenly (typical of bacterial pneumonia) or gradually (common with viral or atypical pneumonia). The following list includes the most frequent manifestations:

• Fever & chills – often above 38 °C (100.4 °F); may be accompanied by sweating.
• Cough – productive (sputum may be yellow, green, rusty, or frothy) or dry.
• Shortness of breath – feeling unable to take a full breath, especially on exertion.
• Chest pain – sharp or stabbing pain that worsens with deep breathing or coughing (pleuritic pain).
• Fatigue & malaise – generalized weakness and lack of energy.
• Rapid heartbeat (tachycardia) – heart rate > 100 beats/min.
• Rapid breathing (tachypnea) – > 20 breaths/min in adults.
• Confusion or changes in mental status – more common in older adults.
• Loss of appetite, nausea, or vomiting.
• Headache – a non‑specific symptom that may accompany systemic infection.
• Blue-tinged lips or fingertips (cyanosis) – sign of low blood oxygen.

Causes and Risk Factors

Infectious agents

• Bacterial – most common: Streptococcus pneumoniae. Others: Haemophilus influenzae, Staphylococcus aureus, Klebsiella pneumoniae, and atypical bacteria such as Mycoplasma pneumoniae, Chlamydophila pneumoniae.
• Viral – influenza, respiratory syncytial virus (RSV), SARS‑CoV‑2 (COVID‑19), adenovirus, parainfluenza.
• Fungal – Histoplasma capsulatum, Candida spp., Pneumocystis jirovecii (especially in HIV/AIDS).
• Other – aspiration of food or gastric contents, chemical inhalation, or allergic pneumonitis.

Risk factors that increase the likelihood of developing pneumonia

• Age < 2 years or > 65 years.
• Smoking or exposure to second‑hand smoke.
• Chronic lung diseases (e.g., COPD, asthma, bronchiectasis).
• Cardiovascular disease, diabetes, liver or kidney disease.
• Immunosuppression (cancer chemotherapy, organ transplantation, HIV/AIDS, corticosteroid therapy).
• Recent upper respiratory infection or influenza.
• Recent hospitalization or residence in a nursing home.
• Malnutrition or alcohol misuse.

Diagnosis

Accurate diagnosis combines a clinical evaluation with targeted investigations.

Clinical assessment

• History taking – onset, exposure, vaccination status.
• Physical exam – listening for crackles, bronchial breathing, or pleural rub.
• Vital signs – fever, heart rate, respiratory rate, blood pressure, oxygen saturation (SpO₂).

Diagnostic tests

• Chest X‑ray – first‑line imaging; shows infiltrates, consolidation, or pleural effusion.
• Computed tomography (CT) scan – higher resolution; used when X‑ray is inconclusive or to assess complications.
• Laboratory studies
  • Complete blood count (CBC) – leukocytosis with left shift suggests bacterial infection; leukopenia may indicate viral or severe disease.
  • C‑reactive protein (CRP) and procalcitonin – markers of inflammation; procalcitonin helps differentiate bacterial from viral causes.
  • Blood cultures – indicated for severe cases or when sepsis is suspected.
  • Sputum Gram stain & culture – isolates causative bacteria; helpful before starting antibiotics.
  • Viral PCR panels – nasopharyngeal swab for influenza, RSV, SARS‑CoV‑2, etc.
• Pulse oximetry & arterial blood gas (ABG) – assess oxygenation; ABG needed for severe respiratory distress.
• Bronchoscopy – reserved for refractory cases, immunocompromised patients, or when aspiration is suspected.

Treatment Options

Treatment is tailored to the underlying cause, severity, patient age, and comorbidities.

Medications

• Antibiotics – first‑line for bacterial pneumonia.
  • Outpatient, otherwise healthy adults: amoxicillin 1 g PO three times daily for 5‑7 days (CDC, 2022).
  • If atypical pathogens suspected: macrolide (azithromycin 500 mg PO daily) or doxycycline.
  • Hospitalized patients: broader coverage with a β‑lactam (ceftriaxone) plus a macrolide, or monotherapy with a respiratory fluoroquinolone (levofloxacin).
• Antivirals – for influenza (oseltamivir) or COVID‑19 (nirmatrelvir/ritonavir) when indicated.
• Corticosteroids – low‑dose dexamethasone (6 mg PO/IV daily) improves outcomes in severe COVID‑19 pneumonia and in select cases of bacterial pneumonia with septic shock.
• Antifungals – e.g., trimethoprim‑sulfamethoxazole for Pneumocystis jirovecii in HIV/AIDS.

Supportive care and procedures

• Oxygen therapy – nasal cannula, face mask, or high‑flow nasal oxygen to keep SpO₂ ≥ 94 % (≥ 90 % in COPD).
• Intravenous fluids – maintain adequate perfusion, especially in febrile or septic patients.
• Chest physiotherapy – incentive spirometry, postural drainage for patients with retained secretions.
• Mechanical ventilation – required for respiratory failure; consider non‑invasive ventilation (CPAP/BiPAP) if appropriate.
• Pleural drainage – thoracentesis or chest tube placement for large pleural effusions or empyema.

Lifestyle and home‑based measures

• Rest and adequate sleep.
• Hydration – at least 2 L of fluids daily unless contraindicated.
• Smoking cessation – reduces inflammation and improves ciliary function.
• Nutrition – high‑protein diet to support immune recovery.
• Vaccinations – keep influenza, COVID‑19, and pneumococcal vaccines up to date (see Prevention section).

Living with Lung Pneumonia

Most people recover fully with appropriate treatment, but the recovery period can be weeks to months, especially in older adults.

Daily management tips

• Medication adherence – finish the full course of antibiotics even if symptoms improve.
• Monitor fever and breathing – record temperature and respiratory rate twice daily.
• Use a peak‑flow meter – if you have underlying asthma or COPD, track lung function.
• Stay mobile – gentle ambulation 2–3 times daily prevents atelectasis and deep‑vein thrombosis.
• Follow-up appointments – usually within 48‑72 hours after starting antibiotics to assess response.
• Pulmonary rehabilitation – consider after hospital discharge to restore exercise tolerance.

Prevention

Many cases of pneumonia are preventable via vaccination, healthy habits, and environmental controls.

• Vaccinations
  • Pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23) – recommended for all adults ≥ 65 years and for high‑risk younger adults.
  • Seasonal influenza vaccine – annual administration.
  • COVID‑19 vaccine & boosters – as per CDC guidelines.
• Hand hygiene – wash hands with soap for at least 20 seconds or use alcohol‑based sanitizer.
• Respiratory etiquette – cover coughs and sneezes with a tissue or elbow.
• Avoid tobacco smoke – smoke‑free homes and cessation programs.
• Manage chronic illnesses – keep diabetes, heart disease, and lung conditions well‑controlled.
• Nutrition & exercise – balanced diet rich in vitamins A, C, D, and zinc; regular moderate‑intensity activity improves immune function.
• Environmental measures – use HEPA filters, reduce indoor air pollutants, avoid overcrowded indoor spaces during outbreaks.

Complications

If pneumonia is not treated promptly or if the patient has significant comorbidities, several serious complications can arise:

• Sepsis and septic shock – systemic inflammation leading to organ failure.
• Pleural effusion and empyema – fluid or pus accumulation in the pleural space.
• Abscess formation – localized collection of pus within lung parenchyma.
• Acute respiratory distress syndrome (ARDS) – severe alveolar damage causing refractory hypoxemia.
• Respiratory failure – may require mechanical ventilation.
• Cardiac complications – arrhythmias, myocardial infarction, or heart failure exacerbation.
• Long‑term pulmonary impairment – reduced lung capacity, especially in smokers or those with pre‑existing COPD.

When to Seek Emergency Care

---

References:

1. World Health Organization. Pneumonia Fact Sheet. 2023.
2. Centers for Disease Control and Prevention. Pneumonia Prevention and Treatment. Updated 2022.
3. Mayo Clinic. Pneumonia. Reviewed 2024.
4. Cleveland Clinic. Pneumonia Overview. Accessed May 2026.
5. National Institutes of Health. Pneumonia. 2023.
6. American Thoracic Society & Infectious Diseases Society of America. Guidelines for the Management of Community‑Acquired Pneumonia. Clin Infect Dis. 2022.
7. U.S. Food and Drug Administration. Drug safety information for antibiotics and antivirals. 2024.

```